Underinsurance and pediatric immunization delivery in the United States

Philip J Smith1, Noelle-Angelique Molinari, Lance E Rodewald

  • 1Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Immunization Services Division, Atlanta, GA 30333, USA. pzs6@cdc.gov

Pediatrics
|December 2, 2009
PubMed

Insights

Underinsured children receiving vaccines at health department clinics (HDCs) have lower timely vaccination rates for newer vaccines. Stable funding is needed for HDCs to cover costs of expensive vaccines for these vulnerable children.

Area of Science:

  • Pediatric Health
  • Immunization Policy
  • Health Economics

Background:

  • A significant portion of children are underinsured, with private insurance that doesn't cover vaccine costs.
  • These children may not qualify for publicly funded vaccines through the Vaccines for Children (VFC) Program unless accessing specific clinics.
  • Primary care providers may refer underinsured children to health department clinics (HDCs) for vaccinations, potentially impacting coverage rates for newer, costlier vaccines.

Purpose of the Study:

  • To estimate the percentage of underinsured children in the U.S. who receive vaccinations at HDCs and are not VFC-entitled.
  • To assess the association between being underinsured, receiving care at an HDC, and achieving timely vaccination coverage.

Main Methods:

  • Analysis of data from 16,621 children aged 19-35 months from the 2007 National Immunization Survey.
  • Comparison of vaccination coverage rates between underinsured children receiving care at HDCs and fully insured children.

Main Results:

  • An estimated 10.5% of children aged 19-35 months were underinsured.
  • Approximately 1.4% were underinsured, received doses at an HDC, and were not VFC-entitled.
  • Underinsured children receiving care at HDCs showed significantly lower vaccination coverage for varicella and PCV7 vaccines compared to fully insured children.

Conclusions:

  • Underinsured children receiving vaccinations at HDCs exhibit lower timely coverage for recently recommended and more expensive vaccines.
  • Sustained and stable funding is crucial for HDCs to procure and administer new and costly vaccines to ensure adequate immunization for underinsured populations.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Methods Of Healthcare Delivery System01:26

Methods Of Healthcare Delivery System

At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...